Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ulcerative Colitis, Active”

Showing 20 of 0 results

Very early researchUnknownNCT01771224
What this trial is testing

Effect of FAn-7 in UC Activity

Who this might be right for
Inflammatory Bowel DiseaseUlcerative Colitis
National Institute of Medical Sciences and Nutrition, Salvador Zubiran 20
Large-scale testing (Phase 3)Study completedNCT00488631
What this trial is testing

An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Janssen Research & Development, LLC 1,228
Large-scale testing (Phase 3)Study completedNCT00096655
What this trial is testing

A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Centocor, Inc. 364
Early research (Phase 1)Study completedNCT02306785
What this trial is testing

TP0502-Pharmaco-Scintigraphic-Study and Amendment

Who this might be right for
Ulcerative Colitis
Tillotts Pharma AG 26
Testing effectiveness (Phase 2)Study completedNCT02289417
What this trial is testing

Efficacy and Safety Study of Apremilast to Treat Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Amgen 170
Not applicableLooking for participantsNCT04121806
What this trial is testing

Diet Intervention Treatment for Active Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Mount Sinai Hospital, Canada 20
Post-approval studies (Phase 4)Active Not RecruitingNCT06964113
What this trial is testing

Filgotinib 200 mg in Korean Participants With Moderately to Severely Active Ulcerative Colitis Under Routine Clinical Practice

Who this might be right for
Ulcerative Colitis
Eisai Korea Inc. 94
Not applicableUnknownNCT02721823
What this trial is testing

Randomized Controlled Trial of Stress Reduction and Lifestyle Modification for Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Universität Duisburg-Essen 92
Not applicableUnknownNCT04197973
What this trial is testing

Association Between Self-reported Web-based SCCAI and Health-related Quality of Life Index in UC Patients

Who this might be right for
Quality of LifeUlcerative Colitis
YooJin Lee 225
Large-scale testing (Phase 3)Study completedNCT00064441
What this trial is testing

FACTS I: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Otsuka Pharmaceutical Development & Commercialization, Inc. 375
Testing effectiveness (Phase 2)Study completedNCT00729872
What this trial is testing

A Phase 2a Study to Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of AG011 in Ulcerative Colitis

Who this might be right for
Moderately Active Ulcerative Colitis
ActoGeniX N.V. 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT06257875
What this trial is testing

Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participants With Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
AbbVie 156
Testing effectiveness (Phase 2)Study completedNCT00628433
What this trial is testing

Safety and Pharmacokinetics Study of HE3286 in Patients With Active, Mild-to-Moderate Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Harbor Therapeutics 27
Large-scale testing (Phase 3)UnknownNCT05771155
What this trial is testing

Efficacy, Safety and Immunogenicity of the Proposed Biosimilar Vedolizumab PB016 in Comparison With Entyvio®

Who this might be right for
Ulcerative Colitis
Polpharma Biologics S.A. 750
Early research (Phase 1)UnknownNCT05404074
What this trial is testing

Pharmacokinetics of Cobitolimod Enemas in Participants With Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
InDex Pharmaceuticals 6
Large-scale testing (Phase 3)Study completedNCT00408174
What this trial is testing

Balsalazide Disodium vs. Mesalamine in Mildly to Moderately Active Ulcerative Colitis

Who this might be right for
Inflammatory Bowel DiseaseUlcerative Colitis
Bausch Health Americas, Inc. 400
Testing effectiveness (Phase 2)Study completedNCT01959282
What this trial is testing

Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Janssen Research & Development, LLC 219
Testing effectiveness (Phase 2)Ended earlyNCT05156125
What this trial is testing

VTX002 Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Oppilan Pharma Ltd 213
Post-approval studies (Phase 4)Study completedNCT01941589
What this trial is testing

Corticosteroids+5-aminosalicylic Acid Compared to Corticosteroids in the Treatment of Moderate-severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Sheba Medical Center 149
Large-scale testing (Phase 3)Active Not RecruitingNCT05528510
What this trial is testing

Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Janssen Research & Development, LLC 418
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation